22 Nw, LP Arvinas, Inc. Transaction History
22 Nw, LP
- $119 Million
- Q2 2025
A detailed history of 22 Nw, LP transactions in Arvinas, Inc. stock. As of the latest transaction made, 22 Nw, LP holds 413,533 shares of ARVN stock, worth $4.19 Million. This represents 2.56% of its overall portfolio holdings.
Number of Shares
413,533Holding current value
$4.19 Million% of portfolio
2.56%Shares
1 transactions
Others Institutions Holding ARVN
# of Institutions
246Shares Held
68.6MCall Options Held
2.99MPut Options Held
534K-
Vanguard Group Inc Valley Forge, PA9.39MShares$95.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$63.5 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.67MShares$37.3 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA3.3MShares$33.5 Million3.14% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.15MShares$21.8 Million0.01% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $540M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...